Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Facundo Davaro

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Urology|October 21, 2019
Chemotherapy increases survival and downstaging of upper tract urothelial cancerFacundo Davaro, Allison May, Coleman McFerrin, et al.
International Urology and Nephrology|July 27, 2019
Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality riskColeman McFerrin, Syed Johar Raza, Allison May, et al.
Clinical Genitourinary Cancer|November 6, 2020
Stage Migration for Upper Tract Urothelial Cell CarcinomaAsef Aziz, Syed J Raza, Facundo Davaro, et al.
The Canadian Journal of Urology|August 31, 2019
Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinomaSyed Johar Raza, Caleb Miller, Allison May, et al.
Frontiers in Urology|August 8, 2025
Increasing surgical wait time does not increase the risk of node positive prostate cancer: Implications for surgical planning during the COVID-19 pandemic and beyondMichael Zaliznyak, Rainey Horwitz, Facundo Davaro, et al.
Journal of Geriatric Oncology|December 12, 2018
Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer DatabaseCaleb Miller, Syed J Raza, Facundo Davaro, et al.
Urology|May 4, 2019
National Trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate CancerAllison May, Jonathon Henke, Daniel Au, et al.
Urology|March 11, 2024
Cost-utility of Initial Management of High-grade T1 Bladder Cancer With Intravesical BCG vs Immediate Radical CystectomyHeather L Huelster, Neil T Mason, Facundo Davaro, et al.
The Journal of Biological Chemistry|May 3, 2014
3-Hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin)-induced 28-kDa interleukin-1β interferes with mature IL-1β signalingFacundo Davaro, Sorcha D Forde, Mark Garfield, et al.
European Urology Oncology|July 19, 2023
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder CancerWei Shen Tan, Ian M McElree, Facundo Davaro, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Urology|October 21, 2019
Chemotherapy increases survival and downstaging of upper tract urothelial cancerFacundo Davaro, Allison May, Coleman McFerrin, et al.
International Urology and Nephrology|July 27, 2019
Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality riskColeman McFerrin, Syed Johar Raza, Allison May, et al.
Clinical Genitourinary Cancer|November 6, 2020
Stage Migration for Upper Tract Urothelial Cell CarcinomaAsef Aziz, Syed J Raza, Facundo Davaro, et al.
The Canadian Journal of Urology|August 31, 2019
Lymph node density for stratification of survival outcomes with node positive upper tract urothelial carcinomaSyed Johar Raza, Caleb Miller, Allison May, et al.
Frontiers in Urology|August 8, 2025
Increasing surgical wait time does not increase the risk of node positive prostate cancer: Implications for surgical planning during the COVID-19 pandemic and beyondMichael Zaliznyak, Rainey Horwitz, Facundo Davaro, et al.
Journal of Geriatric Oncology|December 12, 2018
Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer DatabaseCaleb Miller, Syed J Raza, Facundo Davaro, et al.
Urology|May 4, 2019
National Trends in the Utilization of Androgen Deprivation Therapy for Very Low Risk Prostate CancerAllison May, Jonathon Henke, Daniel Au, et al.
Urology|March 11, 2024
Cost-utility of Initial Management of High-grade T1 Bladder Cancer With Intravesical BCG vs Immediate Radical CystectomyHeather L Huelster, Neil T Mason, Facundo Davaro, et al.
The Journal of Biological Chemistry|May 3, 2014
3-Hydroxyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor (statin)-induced 28-kDa interleukin-1β interferes with mature IL-1β signalingFacundo Davaro, Sorcha D Forde, Mark Garfield, et al.
European Urology Oncology|July 19, 2023
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder CancerWei Shen Tan, Ian M McElree, Facundo Davaro, et al.
Pageof 4